European Office Goswell House 134 Peascod Street Windsor, UK

Slides:



Advertisements
Similar presentations
Phase II/III Design: Case Study
Advertisements

HT Pharmaceuticals Clinical Research Consulting Humphrey Tebit, Principal.
Copyright (c) 2004 Brooks/Cole, a division of Thomson Learning, Inc. Chapter 9 Inferences Based on Two Samples.
Estimating a Population Variance
A Flexible Two Stage Design in Active Control Non-inferiority Trials Gang Chen, Yong-Cheng Wang, and George Chi † Division of Biometrics I, CDER, FDA Qing.
A new group-sequential phase II/III clinical trial design Nigel Stallard and Tim Friede Warwick Medical School, University of Warwick, UK
The Multiple Regression Model Hill et al Chapter 7.
Adaptive Designs for Clinical Trials
Testing and Estimation Procedures in Multi-Armed Designs with Treatment Selection Gernot Wassmer, PhD Institut für Medizinische Statistik, Informatik und.
Background to Adaptive Design Nigel Stallard Professor of Medical Statistics Director of Health Sciences Research Institute Warwick Medical School
Risk Based Monitoring, Sponsor’s Experience Rital Lippman Barnes Clinical Research Manager, MSD.
A Presentation for the European Real Estate Society Annual Conference Stockholm, 2009 Qiulin Ke* and Michael White** *Nottingham Trent University, Nottingham.
Influence of the size of the cohorts in adaptive design for nonlinear mixed effect models: an evaluation by simulation for a pharmacokinetic (PK) and pharmacodynamic.
Reporting of Adverse Drug Reactions: a study among Clinicians
Spreadsheet simulation and trial and error methods in statistics Michael Wood University of Portsmouth, UK
Copyright © 2010, 2007, 2004 Pearson Education, Inc. All Rights Reserved. Section 7-5 Estimating a Population Variance.
Innovations in Management of Cardiovascular Disease for Global Health
MPS/MSc in StatisticsAdaptive & Bayesian - Lect 41 Lecture 4 Sample size reviews 4.1A general approach to sample size reviews 4.2Binary data 4.3Normally.
Unit 6 – confidence intervals
INFERENCE Farrokh Alemi Ph.D.. Point Estimates Point Estimates Vary.
10.1 – Estimating with Confidence. Recall: The Law of Large Numbers says the sample mean from a large SRS will be close to the unknown population mean.
ESTIMATION OF THE MEAN. 2 INTRO :: ESTIMATION Definition The assignment of plausible value(s) to a population parameter based on a value of a sample statistic.
Statistics and probability Dr. Khaled Ismael Almghari Phone No:
CLINICAL TRIALS.
Lecture Slides Elementary Statistics Twelfth Edition
The PRIME Study Dr. Komalkirti Apte
Standard Errors Beside reporting a value of a point estimate we should consider some indication of its precision. For this we usually quote standard error.
Lecture8 Test forcomparison of proportion
Hypotheses and test procedures
Math 4030 – 10b Inferences Concerning Variances: Hypothesis Testing
Inference: Conclusion with Confidence
Confidence Intervals and Hypothesis Tests for Variances for One Sample
The EuLITE (Ongoing) Source
The EuLITE (Ongoing).
Bongile Mzenda, Alexander Gegov, David Brown
Strategies for Implementing Flexible Clinical Trials Jerald S. Schindler, Dr.P.H. Cytel Pharmaceutical Research Services 2006 FDA/Industry Statistics Workshop.
Review of Chapter 11 Comparison of Two Populations
Nat. Rev. Rheumatol. doi: /nrrheum
Introduction to Inference
Sections 6-4 & 7-5 Estimation and Inferences Variation
Sampling Distribution
Sampling Distribution
POINT ESTIMATOR OF PARAMETERS
Confidence Intervals Chapter 10 Section 1.
Chapter 10: The t Test For Two Independent Samples
Graphing Techniques.
From Simulations to the Central Limit Theorem
Basic Concepts PhD Course.
(A) Indirectly age-sex-deprivation-ethnicity standardised procedure ratios for combined eye injection procedures (OPCS-4: C794 and C893) by CCG in England,
Statistical Power.
Measurement of the frenulum using the commercially available Quick Tongue Tie Assessment Kit (Neo Health Services Inc., Coconut Creek, FL, USA). a) Normal.
Effects of reslizumab on asthma quality of life questionnaire (AQLQ) score in Global Initiative for Asthma (GINA) Step 4 and 5 patients. Effects of reslizumab.
Meta-analysis of randomised phase III clinical trials with ALK inhibitors in non-small cell lung cancer (NSCLC) showing similar benefit in male patients.
Figure 1 MOR103 sequential-dose trial flowchart of study population with multiple sclerosis aPatients received 2 doses of study drug before trial withdrawal.
Association of disease parameters at the time of methotrexate reinitiation during the OLE based on propensity score matching. Association of disease parameters.
Effects of reslizumab on asthma control questionnaire-7 (ACQ-7) score in Global Initiative for Asthma (GINA) Step 4 and 5 patients. Effects of reslizumab.
Figure 3 Enrichment strategies for clinical trials
Changes in clinical disease activity over 24 months on a continuous scale in SWEFOT trial participants randomised to triple therapy or anti-TNF with available.
Auditing Compliance with the Privacy Rule
Penalized designs of multi-response experiments
Elliott C. Dasenbrook, Gregory S. Sawicki  Journal of Cystic Fibrosis 
Incidence of choking in London, UK, by gender per 1000 population by age group. Incidence of choking in London, UK, by gender per 1000 population by age.
Covering Principle to Address Multiplicity in Hypothesis Testing
Chapter 6 Confidence Intervals.
Estimating a Population Variance
Physician perspectives on the most useful methods for monitoring α1-antitrypsin deficiency in the clinical trial setting versus clinical practice. Physician.
Physician perspectives on self-administration of i. v. α1-antitrypsin
Exact Inference for Adaptive Group Sequential Clinical Trials
GLOBAL TRANSPLANT DIAGNOSTICS MARKET 2017 – 2025 Published by :Accurize Market Research Pvt. Ltd. Copyright © 2019 Accurize Market Research
Incorporating the sample correlation between two test statistics to adjust the critical points for the control of type-1 error Dror Rom and Jaclyn McTague.
Presentation transcript:

European Office Goswell House 134 Peascod Street Windsor, UK Association of Clinical Research Professionals Academy of Pharmaceutical Physicians and Investigators Global Headquarters 500 Montgomery St Alexandria, VA 22314 USA India Office Bilcare Research Academy 1002, Sai Capital, Senapati Bapat Road, Pune-411 016, India European Office Goswell House 134 Peascod Street Windsor, UK ©copyright ACRP 2008

Adaptive Clinical Trials: What do they Offer?

Objectives for the training 3 3

The role of adaptive methods 4 4

Critical appraisal of adaptive designs 5 5

Sample size modification for a nuisance parameter 6 6

Internal pilots: Wittes & Brittain 7 7

Internal pilots: Properties 8 8

Internal pilots: Properties 9 9

Sample size modification for a nuisance parameter 10 10

Combination tests: The inverse chi squared test 11 11

Combination tests: The inverse normal test 12 12

Sample size re-estimation using a combination test 13 13

Sample size re-estimation using a combination test 14 14

Sample size modification for a nuisance parameter 15 15

Group sequential tests 16 16

Error spending group sequential tests 17 17

Sample size modification for a nuisance parameter 18 18

Information monitoring 19 19

Sample size modification for a nuisance parameter 20 20

2. Sample size modification to increase power 21 21

Sample size modification to increase power 22 22

Sample size modification to increase power 23 23

Sample size modification to increase power 24 24

Sample size modification to increase power 25 25

Sample size modification to increase power 26 26

Sample size modification to increase power 27 27

Sample size modification to increase power 28 28

Sample size modification to increase power 29 29

Sample size modification to increase power 30 30

Sample size modification to increase power 31 31

3. Switching to a patient sub-population 32 32

Enrichment: Example 33 33

Multiple testing procedures 34 34

Closed testing procedures (Marcus et al, Biometrika, 1976) 35 35

Enrichment: Example 36 36

Enrichment: Example 37 37

Enrichment: Example 38 38

Enrichment: A closed testing procedure 39 39

Enrichment: An adaptive design 40 40

Enrichment: An adaptive design 41 41

Enrichment: An adaptive design 42 42

Simulation results: Power of non-adaptive and adaptive designs 43 43

Increasing power for finding a sub-population effect 44 44

Increasing power for finding a sub-population effect 45 45

Enrichment: Example 46 46

Increasing power for finding a sub-population effect 47 47

Conclusions 48 48